Surgery and Soft-Tissue Tumours

By  

Sarcoma, Vol. 6, Iss. 1, 2002-05 ,pp. : 19-24

Informa Healthcare

Access to resources Recommend Favorite

Cryoimmunology for malignant bone and soft-tissue tumors

By Nishida Hideji  

International Journal of Clinical Oncology, Vol. 16, Iss. 2, 2011-04 ,pp. : 109-117

Springer Publishing Company

Access to resources Recommend Favorite

Soft tissue tumours of the retroperitoneum

By Van Roggen J. Frans Graadt   Hogendoorn Pancras C.W.  

Sarcoma, Vol. 4, Iss. 1-2, 2000-03 ,pp. : 17-26

Informa Healthcare

Access to resources Recommend Favorite

Absence of telomerase activity in malignant bone tumors and soft-tissue sarcomas

By Lauer Nina K.   Maier Sandra M.   Oberringer Martin   Schulte Michael   Mutschler Wolf   Hanselmann Rainer G.   Schartl Manfred   Scherer Stefan J.   Wirbel Reiner J.  

Sarcoma, Vol. 6, Iss. 1, 2002-03 ,pp. : 43-46

Informa Healthcare

Access to resources Recommend Favorite

Imatinib mesylate (STI-571 Glivec(R), Gleevec(TM)) is an active agent for gastrointestinal stromal tumours, but does not yield responses in other soft-tissue sarcomas that are unselected for a molecular target - Results from an EORTC Soft Tissue and Bone Sarcoma Group phase II study

By Verweij J.   van Oosterom A.   Blay J.-Y.   Judson I.   Rodenhuis S.   van der Graaf W.   Radford J.   Le Cesne A.   Hogendoorn P.C.W.   di Paola E.D.   Brown M.   Nielsen O.S.  

European Journal of Cancer, Vol. 39, Iss. 14, 2003-09 ,pp. : 2006-2011

Elsevier

Access to resources Recommend Favorite